Personalized measurable residual disease assays for acute myeloid leukemia guided by whole-genome sequencing

Niveditha Ravindra1, Rasha W Al-Ali2, Justin Lack3

  • 1Laboratory of Myeloid Malignancies, National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, MD.

Haematologica
|July 23, 2026
PubMed

Related Concept Videos